Prophylactic or Early Use of Eculizumab and Graft Survival in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome in the United States: Research Letter

INTRODUCTION: Among kidney transplant recipients (KTRs) with end-stage kidney disease (ESKD) due to atypical hemolytic uremic syndrome (aHUS), recurrence is associated with poor allograft outcomes. We compared graft and patient survival of aHUS KTRs with and without prophylactic/early use of eculizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Plasse, Richard A., Olson, Stephen W., Yuan, Christina M., Agodoa, Lawrence Y., Abbott, Kevin C., Nee, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Clinical Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020226/
https://www.ncbi.nlm.nih.gov/pubmed/33868691
http://dx.doi.org/10.1177/20543581211003763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020226/
https://www.ncbi.nlm.nih.gov/pubmed/33868691
http://dx.doi.org/10.1177/20543581211003763

Ejemplares similares